Rituximab: Active treatment of central nervous system involvement by non-Hodgkin's lymphoma?

被引:79
作者
Ruhstaller, TW [1 ]
Amsler, U [1 ]
Cerny, T [1 ]
机构
[1] Kantonsspital St Gallen, Klin Innere Med C, CH-9007 St Gallen, Switzerland
关键词
D O I
10.1023/A:1008371602708
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:374 / 375
页数:3
相关论文
共 1 条
[1]   Rituximab chimeric Anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma:: Half of patients respond to a four-dose treatment program [J].
McLaughlin, P ;
Grillo-López, AJ ;
Link, BK ;
Levy, R ;
Czuczman, MS ;
Williams, ME ;
Heyman, MR ;
Bence-Bruckler, I ;
White, CA ;
Cabanillas, F ;
Jain, V ;
Ho, AD ;
Lister, J ;
Wey, K ;
Shen, D ;
Dallaire, BK .
JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (08) :2825-2833